What killed Ozzy Osbourne? Death certificate confirms cause
Ozzy Osbourne, the legendary frontman of Black Sabbath and one of the most iconic figures in rock history, passed away on July 22, 2025, at the age of 76. Known worldwide as the Prince of Darkness , Ozzy's death marks the end of an era for heavy metal and rock fans across the globe. Official Cause of Death Revealed
According to his death certificate, Ozzy died from an out-of-hospital cardiac arrest caused by an acute myocardial infarction — a medical term for a heart attack. Additional contributing factors included coronary artery disease and Parkinson's disease with autonomic dysfunction, a condition that affects involuntary bodily functions like heart rate and blood pressure.
His death certificate also proudly noted his occupation as 'Songwriter, Performer and Rock Legend,' reflecting his immense impact on the music world. A Long Battle With Health Issues
Ozzy had been battling multiple serious health problems for years. He was first diagnosed with Parkinson's disease in the early 2000s, though the diagnosis was publicly confirmed only in 2020. The condition affected his balance, mobility, and speech, but he continued to remain active and creative despite it.
His health further declined after a quad bike accident in 2003, which left him with severe injuries, followed by a bad fall in 2019 that worsened his spinal condition. Multiple surgeries and infections over the years took a heavy toll on his body.
Ahmedabad Plane Crash
Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
15 hours ago
- New York Post
I'm a neuroscientist — this ‘one-page miracle' can boost brain health, plus why I nicknamed my mind ‘Hermie'
It may be time to think outside the box. Many Americans will experience some level of brain decline as they age, ranging from mild cognitive impairment to dementia. Maintaining a sharp mind is crucial — strong cognitive function is vital for overall well-being and a high quality of life. Advertisement 5 Dr. Daniel Amen is a double board-certified psychiatrist, a brain-imaging researcher and the founder of Amen Clinics. Courtesy of Dr. Amen Perhaps you've heard that you should eat a healthy diet, exercise regularly, engage in mentally stimulating activities, get enough sleep and make social connections to support your brain. Dr. Daniel Amen, a double board-certified psychiatrist and brain-imaging researcher in California, has five other bright ideas for powering your think tank. Give your mind a name Advertisement 'Naming your mind creates psychological distance between you and the noise in your head,' explained Amen, founder of Amen Clinics. 5 During self-reflection, distance yourself from the noise in your head by giving your mind a name of its own. Rido – 'Research on 'distanced self-talk' shows it boosts emotional regulation, self-control and even decision-making.' Advertisement Distanced self-talk, also known as third-person self-talk, is when you refer to yourself using your own name or 'you' instead of 'I,' 'me' or 'my' during self-reflection. Amen revealed that he named his mind 'Hermie' after the 'troublemaker' pet raccoon he had as a teen. 'The next time your mind starts ranting about how you're a failure, blame Hermie (or whatever name you give to your mind) — and put her back in her cage,' Amen said. Kill automatic negative thoughts Automatic negative thoughts (ANTs) are toxic, frequently irrational ideas that pop into your head, especially during stressful situations. Advertisement If you feel sad, mad, nervous or out of control, write down your ANTs and ask yourself these simple questions championed by spiritual mentor and author Byron Katie. 5 Journaling can help you kill the spontaneous, irrational thoughts that pop up in your brain. Farknot Architect – Is it true? Is it absolutely true? Do I know it with 100% certainty? How do I feel when I believe this thought? How would I feel if I couldn't have this thought? Now, turn the thought around to its opposite. Is the opposite of the thought true or even truer than the original thought? Try table tennis Members of PingPongParkinson will tell you that playing table tennis has delayed the progression of their Parkinson's disease symptoms because the game requires concentration, hand-eye coordination and balance and fosters social interaction. 'Table tennis is like aerobic chess,' Amen said. 'You have to get your eyes, hands and feet all working together while you think about the spin on the ball.' 5 Table tennis requires concentration, hand-eye coordination and balance. Brian Zak/NY Post Amen said the activity works the cerebellum, the brain region located at the back and bottom of the skull, which is key for coordinating movements and influencing thought. Advertisement He also noted that table tennis causes very few head injuries. Consume mushrooms Certain fungi are rich in antioxidants, anti-inflammatory compounds and polysaccharides that help protect the brain from oxidative stress and aging, Amen said. 5 Studies suggest that lion's mane mushrooms (shown here) may boost memory and focus. nungning20 – Advertisement 'Science shows that mushrooms like reishi, Cordyceps and lion's mane may help reduce anxiety, improve memory impairment and boost mood,' he added. 'Together, these mushrooms help support memory, focus, mood, balance and long-term brain resilience.' Create a 'one-page miracle' 'If you want to be successful in any area of your life, you have to tell your brain what you want over and over again,' Amen advised. 'Then ask yourself if your behavior is getting you what you want,' he continued. 'Does it fit your goals? Do this now and post it where you can see it every day.' Advertisement This exercise is called a 'one-page miracle' — write what you want in key areas of your life. Don't document what you don't want. Look at it every day and assess if you are doing things to reach your goals.
Business Upturn
a day ago
- Business Upturn
What killed Ozzy Osbourne? Death certificate confirms cause
By Aman Shukla Published on August 5, 2025, 21:38 IST Ozzy Osbourne, the legendary frontman of Black Sabbath and one of the most iconic figures in rock history, passed away on July 22, 2025, at the age of 76. Known worldwide as the Prince of Darkness , Ozzy's death marks the end of an era for heavy metal and rock fans across the globe. Official Cause of Death Revealed According to his death certificate, Ozzy died from an out-of-hospital cardiac arrest caused by an acute myocardial infarction — a medical term for a heart attack. Additional contributing factors included coronary artery disease and Parkinson's disease with autonomic dysfunction, a condition that affects involuntary bodily functions like heart rate and blood pressure. His death certificate also proudly noted his occupation as 'Songwriter, Performer and Rock Legend,' reflecting his immense impact on the music world. A Long Battle With Health Issues Ozzy had been battling multiple serious health problems for years. He was first diagnosed with Parkinson's disease in the early 2000s, though the diagnosis was publicly confirmed only in 2020. The condition affected his balance, mobility, and speech, but he continued to remain active and creative despite it. His health further declined after a quad bike accident in 2003, which left him with severe injuries, followed by a bad fall in 2019 that worsened his spinal condition. Multiple surgeries and infections over the years took a heavy toll on his body. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Newsweek
6 days ago
- Newsweek
A Doctor's Plea From a Nation Asleep on Brain Disease
Advocates for ideas and draws conclusions based on the interpretation of facts and data. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. As a physician who once treated pain, I now endure the unimaginable. Amyotrophic lateral sclerosis (ALS) has left me quadriplegic, dependent on a tracheostomy to breathe and a feeding tube to eat. Diagnosed at 35, my career ended abruptly. My family's story reveals the scale of the coming storm—my father battles Alzheimer's, my uncle succumbed to Parkinson's, and my grandmother to Lewy body dementia. We are not outliers; we represent a silent epidemic. Neurodegenerative diseases are surging, yet our nation slumbers, unaware of the devastation ahead. The public's complacency is by design, built on a statistical illusion. ALS, fatal since 1869, exemplifies this peril. With a median survival of 2-3 years, it strikes about 1 in 300 people in their lifetime, which predicts that over 1 million people now alive in the U.S. will succumb to ALS. Yet, under federal law, it is labeled "rare" because that definition is based on prevalence—a static snapshot of how many people are living with a disease at one time. Because ALS kills its victims so quickly, the number of living patients stays below the 200,000-person "rare" threshold. Its very lethality ensures it is never treated like the mainstream public health crisis it is. This paradox obscures a terrifying forecast: a projected 69 percent global increase in ALS cases by 2040. This illusion of rarity perpetuates a deadly inaction that extends to all brain diseases. Alzheimer's already affects over 7 million Americans and is projected to strike nearly 13 million by 2050, costing our economy $384 billion in 2025—and projected to nearly $1 trillion annually by mid-century. Exterior view of the headquarters of the U.S. Food and Drug Administration (FDA). Exterior view of the headquarters of the U.S. Food and Drug Administration (FDA). Getty Images The failure to confront this crisis stems from a Tale of Two Agencies within the Food and Drug Administration (FDA). In 2017, Congress established the Oncology Center of Excellence (OCE), a dynamic hub that has revolutionized cancer treatment, accounting for 85 percent of all accelerated approvals in the last decade. This success is the result of focused will and resources; National Institutes of Health (NIH) funding for cancer has topped $7.2 billion, compared to $2.8 billion for neuroscience. Neurology has no such center. Lacking an institutional home, it is fragmented, slow, and characterized by a risk aversion unthinkable in oncology. This disparity persists because of the tragic nature of these diseases. In the 1980s, ACT UP activists staged "die-ins" to force a reluctant government to fight AIDS. Patients with ALS, Huntington's, or Alzheimer's cannot mount a similar protest—we are physically silenced and immobilized, unable to "seize the FDA." This vulnerability places a unique moral obligation on our leaders to act proactively on behalf of the voiceless. The new FDA leadership now arrives with bold promises of change, posing a question that haunts everyone touched by an untreatable neurological disease: Will this time be different? Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. vows to "sweep away barriers" and to "figure out new ways ... of accelerating approvals for drugs and treatments that treat rare diseases." FDA Commissioner Marty Makary has several times asked why it takes 10 years for a drug to get to market and proposes a "conditional approval" pathway based on a "plausible mechanism." Center for Biologics Evaluation and Research (CBER) Director Vinay Prasad promised to "take action at the first sign of promise for rare diseases." For the ALS community, these words are now a crisis of credibility. In a disease that has a median survival of 2-3 years, we are asking for regulatory flexibility for a treatment that began its Phase 1 trial in 2011 and was granted FDA Fast Track designation in 2014. As a petitioner on the July 3 citizens' petition for a stem cell therapy known as NurOwn, my community has presented the FDA with a clear test. Ultimately, we are seeking accelerated approval based on new, unprecedented survival data from an expanded access program—data that exceeds the extension of survival of many approved cancer therapies. But the initial request is simpler: invite the sponsor to resubmit its application for a full review. Ours is a request for due process to give a voice to the voiceless—the lowest possible bar for the Trump administration to demonstrate its promised flexibility. A clear, bipartisan solution has already failed once. The Neuroscience Center of Excellence Act, introduced in 2021 to replicate oncology's success for brain disease, stalled in committee. It is time for our leaders to find the political will that has been so catastrophically absent. Congress must immediately revive and pass the Neuroscience Center of Excellence Act. The FDA, in turn, must match its leaders' promises with action by granting our petition a review. The science is poised for breakthroughs, but it is being shackled by a broken system. For those of us on a deadline, this is not a policy debate. It is a death sentence. Awaken now, before this silent storm engulfs us all. The voiceless can't wait. Dr. Shahriar Minokadeh, a former anesthesiologist trained at Johns Hopkins and pain management at UC San Diego, types via an eye-gaze device. The views expressed in this article are the writer's own.
